Kasim has over 25 years of experience in Drug Discovery and innovative pharmaceutical research, and building leading teams and companies in the pharma/biotech industry. He co-founded Advinus Therapeutics, a TATA Enterprise, where he began as the Chief Scientific Officer and eventually became its CEO. Previously Kasim was Vice President, New Drug Discovery Research, at Ranbaxy Laboratories. He began his career at the Bristol-Myers Squibb Pharmaceutical Research Institute in Princeton, where he was Director of Drug Discovery Department focused on Cardiovascular and Metabolic Diseases, Inflammation, and Cancer. Kasim is a graduate of the Indian Institute of Technology, Bombay, in Chemistry. He received his doctoral degree from the Institute of Molecular Biophysics, Florida State University, Tallahassee, followed by post-doctoral fellowship at the Yale University School of Medicine.